Preventing cervical cancer through quick self-sampling and testing
PROGRESS: PRevention of cervical cancer using the Genotyping scREening and Same-day Self-sampling
This study is testing a new, easy, and affordable way for women to check for high-risk HPV, which can lead to cervical cancer, so they can get quick results and same-day treatment, especially in places where cervical cancer is more common.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Atila Biosystems, INC. NIH-funded |
| Lab location | 1 site (Sunnyvale, UNITED STATES) |
| Project ID | NIH-10696230 on NIH RePORTER |
What this research studies
This research focuses on developing a low-cost, efficient method for cervical cancer prevention by utilizing a new HPV self-sampling test. The modified AmpFire® HPV Genotyping test allows for rapid identification of high-risk HPV types and provides immediate results, enabling same-day treatment for women at high risk of developing cervical cancer. By streamlining the screening process, the research aims to improve access to care, particularly in low- and middle-income countries where cervical cancer rates are highest.
Who could benefit from this research
Good fit: Ideal candidates for this research include women, particularly adolescents and young adults, who are at risk for cervical cancer and live in low- and middle-income countries.
Not a fit: Patients who are not at risk for cervical cancer or those who have already been diagnosed and treated for the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence and mortality of cervical cancer by facilitating timely diagnosis and treatment.
How similar studies have performed: Other research has shown promise in using self-sampling and rapid testing for HPV, indicating that this approach could be effective in improving cervical cancer screening and treatment.
Where this research is happening
Sunnyvale, UNITED STATES
- Atila Biosystems, INC. — Sunnyvale, United States (Active)
Researchers
- Principal investigator: Wang, Youxiang — Atila Biosystems, INC.
- Study coordinator: Wang, Youxiang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.